RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug that is effective against immature leukemic progenitors

Activity: Talk or presentation at external institutions/events › Talk/Presentation › Invited